News from cardium therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Mar 14, 2013, 09:00 ET Cardium Receives ISO Certification for Excellagen

Cardium Therapeutics (NYSE MKT: CXM) today announced that it has received ISO 13485:2003 certification for its Excellagen® advanced wound care...


Feb 12, 2013, 09:00 ET Cardium's Excellagen® Awarded American Podiatric Medical Association Seal of Approval

Cardium Therapeutics (NYSE MKT: CXM) announced today that the American Podiatric Medical Association (APMA) has granted its prestigious Seal of...


Jan 29, 2013, 09:00 ET Cardium Announces Presentation at The 2013 Cell & Gene Therapy Forum

Cardium Therapeutics (NYSE MKT: CXM) today announced a presentation at the 2013 Phacilitate Annual Cell & Gene Therapy Forum in Washington, DC. The...


Jan 16, 2013, 09:00 ET Cardium Exchange Listing Compliance Plan Accepted by NYSE MKT

Cardium Therapeutics (NYSE MKT: CXM) today reported that its exchange listing compliance plan submitted on December 6, 2012 has been accepted by the...


Jan 04, 2013, 09:00 ET Cardium To Present At Biotech Showcase 2013 Investment Conference And Report On New Cardium Initiatives

Cardium Therapeutics (NYSE MKT: CXM) today announced that Christopher J. Reinhard, the Company's Chairman & CEO, will present at the Biotech Showcase ...


Jan 03, 2013, 09:00 ET Cardium Announces Sales and Distribution Agreement With Academy Medical to Promote Excellagen Clinical Adoption by U.S. Government Medical Providers

Cardium Therapeutics (NYSE MKT: CXM) today announced a distribution agreement with Academy Medical, LLC to market, sell and distribute Excellagen to...


Dec 06, 2012, 05:43 ET Cardium Reports On NYSE MKT Noncompliance Notice And Compliance Plan

Cardium Therapeutics (NYSE MKT: CXM) reported on a communication from staff of its current listing exchange that it considered the company to be...


Nov 19, 2012, 09:00 ET Cardium Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease

Cardium Therapeutics (NYSE MKT: CXM) today announced a winning patent decision in Europe and successful resolution of a long-standing competition...


Nov 14, 2012, 09:00 ET Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments

Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the third quarter ended September 30, 2012 and reported on other...


Nov 13, 2012, 09:00 ET Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference

Cardium Therapeutics (NYSE MKT: CXM) today announced the presentation of two Excellagen® poster presentations at the Desert Foot 2012 High Risk...


Nov 06, 2012, 09:00 ET European Union's First Gene Therapy Approval Represents Major Advancement For Industry

Cardium Therapeutics (NYSE MKT: CXM) today reported that uniQure's Glybera® (alipogene tiparvovec) approval by the European Commission, the first...


Oct 01, 2012, 09:00 ET Cardium Announces the Acquisition of To Go Brands

Cardium Therapeutics (NYSE MKT: CXM) today announced that its MedPodium® operating unit has acquired the assets, business and product portfolio of...


Sep 24, 2012, 09:00 ET Cardium To Present At 2012 Noble Financial Life Sciences Investor Conference

Cardium Therapeutics (NYSE MKT: CXM) today announced that Christopher J. Reinhard, Chairman & CEO will present at the BioX Noble Financial Life...


Sep 20, 2012, 09:00 ET Cardium Announces Medical Advisory Board To Support Excellagen Advanced Wound Care Product

Cardium Therapeutics (NYSE MKT: CXM) today announced the formation of the new Excellagen Medical Advisory Board, comprising leading practitioners,...


Aug 14, 2012, 09:00 ET Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments

Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the second quarter ended June 30, 2012 and reported on other recent...


Aug 01, 2012, 09:00 ET Cardium's Excellagen® Named As Top 10 Innovation In Podiatry

Cardium Therapeutics (NYSE MKT: CXM) today announced that its professional-use Excellagen® (formulated collagen gel 2.6%) wound care product was...


Jul 26, 2012, 09:00 ET Published Findings In Human Gene Therapy Methods Journal Demonstrate Cardium's New Catheter-Based Method Significantly Boosts Gene Delivery To The Heart

Cardium Therapeutics (NYSE MKT: CXM) today announced the publication of preclinical findings demonstrating that cardiac ischemia plays an important...


Jun 14, 2012, 09:00 ET Cardium To Present At The Marcum MicroCap Conference

Cardium Therapeutics (NYSE MKT: CXM) today announced that Christopher J. Reinhard, Chairman & CEO will present at the Marcum MicroCap Conference on...


Jun 12, 2012, 09:00 ET Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation

Cardium Therapeutics (NYSE MKT: CXM) today announced an agreement with Advanced Biosciences Research, an affiliate of bioRASI, for the planned...


May 17, 2012, 09:00 ET Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences

Cardium Therapeutics (NYSE MKT: CXM) today announced that Christopher J. Reinhard, Chairman & CEO will present a corporate overview and participate...


May 16, 2012, 09:00 ET Cardium Reports New Catheter-Based Methods Significantly Boost Cardiac Gene Delivery In Late-Breaking Presentation at 2012 American Society of Gene & Cell Therapy Meeting

Cardium Therapeutics (NYSE MKT: CXM) today announced a late-breaking poster presentation at the American Society of Gene & Cell Therapy (ASGCT) 15th...


May 15, 2012, 09:05 ET Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion

Cardium Therapeutics (NYSE Amex: CXM) today announced an agreement with UK-based Angel Biomedical Limited, a subsidiary of Angel Biotechnology...


May 15, 2012, 09:00 ET Cardium Presents First Quarter 2012 Financial Results and Recent Developments

Cardium Therapeutics (NYSE Amex: CXM) today presented its financial results for the first quarter ended March 31, 2012, and other recent developments....


Apr 19, 2012, 06:43 ET Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care

Cardium Therapeutics (NYSE Amex: CXM) is currently exhibiting its new FDA-cleared Excellagen® professional-use, syringe-based wound care product for...


Mar 30, 2012, 09:15 ET Cardium Presents Fourth Quarter and Year-End 2011 Financial Results and Recent Developments

Cardium Therapeutics (NYSE AMEX: CXM) today presented highlights of financial results for its fourth quarter and fiscal year ended December 31, 2011, ...